Incyte (INCY) News Today $67.86 -1.08 (-1.57%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$67.86 0.00 (-0.01%) As of 07/18/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INCY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Victory Capital Management Inc. Has $49.24 Million Stock Position in Incyte Corporation (NASDAQ:INCY)July 19 at 6:32 AM | marketbeat.comIncyte’s Phase 3 Study on Ruxolitinib Cream: A Potential Game-Changer for Hidradenitis SuppurativaJuly 18 at 12:08 PM | tipranks.comIncyte’s Asthma Study: A Potential Game-Changer for Investors?July 18 at 12:08 PM | tipranks.comAllegiance Financial Group Advisory Services LLC Increases Position in Incyte Corporation (NASDAQ:INCY)July 18 at 11:35 AM | marketbeat.comHussman Strategic Advisors Inc. Boosts Holdings in Incyte Corporation (NASDAQ:INCY)July 18 at 10:38 AM | marketbeat.comPatton Albertson Miller Group LLC Decreases Stake in Incyte Corporation (NASDAQ:INCY)July 18 at 9:26 AM | marketbeat.comIncyte Executives Cash In: See How Much They Made!July 17 at 10:12 PM | tipranks.comIncyte’s Promising Phase 3 Study on Povorcitinib for Hidradenitis SuppurativaJuly 17 at 12:43 PM | tipranks.comParcion Private Wealth LLC Buys Shares of 5,562 Incyte Corporation (NASDAQ:INCY)July 17 at 7:11 AM | marketbeat.comIncyte Corporation (NASDAQ:INCY) EVP Sells $82,225.22 in StockJuly 17 at 6:52 AM | insidertrades.comJPMorgan Chase & Co. Cuts Incyte (NASDAQ:INCY) Price Target to $67.00July 17 at 4:48 AM | americanbankingnews.comWilliam Blair Forecasts Incyte's Q2 Earnings (NASDAQ:INCY)July 17 at 3:02 AM | americanbankingnews.comIncyte Corporation (NASDAQ:INCY) EVP Sells $82,225.22 in StockJuly 16, 2025 | marketbeat.comInsider Selling: Incyte Corporation (NASDAQ:INCY) EVP Sells 1,192 Shares of StockJuly 16, 2025 | marketbeat.comSteven H. Stein Sells 14,952 Shares of Incyte Corporation (NASDAQ:INCY) StockJuly 16, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) EVP Sells $1,023,763.44 in StockJuly 16, 2025 | marketbeat.comIncyte EVP Flannelly sells $83k in sharesJuly 16, 2025 | investing.comIncyte’s Phase 3 Study on Povorcitinib: A Potential Game-Changer for Hidradenitis SuppurativaJuly 16, 2025 | msn.comMQS Management LLC Makes New $237,000 Investment in Incyte Corporation (NASDAQ:INCY)July 16, 2025 | marketbeat.comCwm LLC Has $6.51 Million Stake in Incyte Corporation (NASDAQ:INCY)July 16, 2025 | marketbeat.comCerity Partners LLC Has $8.04 Million Stock Position in Incyte Corporation (NASDAQ:INCY)July 16, 2025 | marketbeat.comSun Pharma launches Leqselvi in US; settles litigation with Incyte CorpJuly 15, 2025 | msn.comWilliam Blair Has Negative Forecast for Incyte Q2 EarningsJuly 15, 2025 | marketbeat.comDakota Wealth Management Acquires Shares of 51,467 Incyte Corporation (NASDAQ:INCY)July 15, 2025 | marketbeat.comJPMorgan Chase & Co. Lowers Incyte (NASDAQ:INCY) Price Target to $67.00July 14, 2025 | marketbeat.comIndia's Sun Pharma launches hair loss drug Leqselvi in US after patent settlementJuly 14, 2025 | msn.comSun Pharma settles litigation with Incyte Corp over hair loss drug LeqselviJuly 14, 2025 | msn.comDekaBank Deutsche Girozentrale Trims Stock Holdings in Incyte Corporation (NASDAQ:INCY)July 12, 2025 | marketbeat.comBank of New York Mellon Corp Raises Stake in Incyte Corporation (NASDAQ:INCY)July 11, 2025 | marketbeat.comIncyte’s Q2 2025 Earnings: What to ExpectJuly 10, 2025 | finance.yahoo.comIncyte to Report Second Quarter Financial ResultsJuly 10, 2025 | gurufocus.comLbp Am Sa Sells 7,738 Shares of Incyte Corporation (NASDAQ:INCY)July 10, 2025 | marketbeat.comTeacher Retirement System of Texas Has $2.71 Million Stake in Incyte Corporation (NASDAQ:INCY)July 10, 2025 | marketbeat.comWilliam Blair Maintains ‘Hold’ Rating on Incyte Corporation (INCY), Citing Future Revenue UncertaintiesJuly 9, 2025 | msn.comIFM Investors Pty Ltd Has $2.43 Million Stake in Incyte Corporation (NASDAQ:INCY)July 8, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) EVP Sells $41,097.39 in StockJuly 8, 2025 | insidertrades.comInsider Selling: Incyte Corporation (NASDAQ:INCY) EVP Sells 599 Shares of StockJuly 7, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) EVP Vijay K. Iyengar Sells 8,617 SharesJuly 7, 2025 | marketbeat.comInsider Selling: Incyte Corporation (NASDAQ:INCY) EVP Sells 10,903 Shares of StockJuly 7, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Trims Stock Position in Incyte Corporation (NASDAQ:INCY)July 7, 2025 | marketbeat.comIncyte Corporation (NASDAQ:INCY) Receives Consensus Rating of "Hold" from AnalystsJuly 7, 2025 | marketbeat.comNew York State Teachers Retirement System Sells 7,383 Shares of Incyte Corporation (NASDAQ:INCY)July 4, 2025 | marketbeat.comIncyte’s Phase 1 Study on INCB057643: A Potential Game-Changer for Myelofibrosis Treatment?July 3, 2025 | tipranks.comIncyte’s Phase 2 Study on INCB099280: A Potential Breakthrough in Skin Cancer TreatmentJuly 3, 2025 | tipranks.comIncyte’s Phase 3 Study Update: Potential Market Impact for HNSCC TreatmentJuly 3, 2025 | tipranks.comIncyte: New CEO Brings A New Possible OutcomeJuly 3, 2025 | seekingalpha.comIncyte’s Future Hinges on Pipeline Potential Amid Jakafi Exclusivity LossJuly 3, 2025 | tipranks.comSumitomo Mitsui Trust Group Inc. Purchases 25,844 Shares of Incyte Corporation (NASDAQ:INCY)July 3, 2025 | marketbeat.comIncyte Corp (INCY) Announces Equity Inducement Awards for New CEO Bill Meury | INCY stock newsJuly 2, 2025 | gurufocus.comIncyte’s Promising Phase 1/2 Study: A New Hope for Advanced Solid TumorsJuly 2, 2025 | tipranks.com Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address INCY Media Mentions By Week INCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INCY News Sentiment▼0.180.59▲Average Medical News Sentiment INCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INCY Articles This Week▼3518▲INCY Articles Average Week Get Incyte News Delivered to You Automatically Sign up to receive the latest news and ratings for INCY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AbbVie News Today Alnylam Pharmaceuticals News Today Biogen News Today United Therapeutics News Today Neurocrine Biosciences News Today Exelixis News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Halozyme Therapeutics News Today Madrigal Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INCY) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Incyte Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Incyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INCY Stock Alerts